Extrapulomnary-extragastrointestinal manifestations in patients with COVID-19

https://doi.org/10.53730/ijhs.v6nS4.8190

Authors

  • Gamal Mohammad Mohammad Soliman Hepatogastroentrology and infectious diseases Medicine, Faculty of Medicine, Al-Azhar University, Egypt
  • Yasser Mohamed Mohamed El –Dessouky Hepatogastroentrology and infectious diseases Medicine, Faculty of Medicine, Al-Azhar University, Egypt
  • Ramadan Salama Mohamed Hepatogastroentrology and infectious diseases Medicine, Faculty of Medicine, Al-Azhar University, Egypt

Keywords:

Clinical severity, COVID-19, Extra-gastrointestinal, Extra-pulmonary

Abstract

Background: COVID-19 (coronavirus disease-2019) is a multisystem disorder. In terms of severity, the disease can manifest as mild, moderate, severe, or critical. Depending on the severity of the case, the patient may exhibit extrapulmonary or extragastrointestinal symptoms. Objective: The purpose of this research was to evaluate the extrapulmonary and extragastrointestinal symptoms of COVID-19 infection in patients and to make accurate predictions for follow-up care. Patient and method: This prospective observational study was conducted on (404) COVID-19 infected patients with positive COVID-19 PCR at El-sheikh Zayed Al-Nahyan Hospital from January 1st to June 30th, 2021. Results: There was a statistically significant difference between the clinical severity of illness regrding patient demographic features such as older age, male gender, co morbidities such as diabetes and hypertension; extra pulmonary – extra gastrointestinal manifestations. Conclusion: There is a correlation between COVID-19 illness that is severe and critical and the presence of preexisting conditions such as diabetes and cardiovascular disease, as well as older age, fatigue, anorexia, abdominal pain, diarrhoea, expectoration, dyspnea, chest pain, altered mental status, morbilliform rash, acute kidney injury, acute cardiac injury, and eye manifestations.

Downloads

Download data is not yet available.

References

Machhi, Jatin. “The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.” Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology, 2020; 15(3): 359-386. doi:10.1007/s11481-020-09944-5

Zou X. “Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.” Frontiers of medicine, 2020: 14(2): 185-192. doi:10.1007/s11684-020-0754-0

Elrobaa, Islam H, Karl J. “COVID-19: Pulmonary and Extra Pulmonary Manifestations.” Frontiers in public health 2021; 9: 711616. doi:10.3389/fpubh.2021.711616

Shimaa E, Ibrahim A, Marwa S, Walaa E, Mohamed A, Amany G, et al. "Clinical and Laboratory Predictors for ICU Admission ‎among COVID-19 Infected Egyptian Patients, A ‎multi-Center Study ‎". Afro-Egyptian Journal of Infectious and Endemic Diseases, 2021; 11(3): 284-294. doi: 10.21608/aeji.2021.82473.1155

Jia He, Bo Wu. Characteristic electrocardiographic manifestations in patients with COVID-19. Can J Cardiol. 2020; 36: 966.e1–966.e4.

Spiezia L. “COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.” Thrombosis and haemostasis. 2020; 120 (6): 998-1000. doi:10.1055/s-0040-1710018

Wang Ming-Ke. “COVID-19 and the digestive system: A comprehensive review.” World journal of clinical cases, 2021; 9(16): 3796-3813. doi:10.12998/wjcc.v9.i16.3796

Immacolata A, Elena B. Gender differences in patients with COVID-19: a narrative review. Monaldi Arch Chest Dis. 2020; 90: 318–24.

Mao R. “Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.” The lancet. Gastroenterology & hepatology. 2020; 5(7): 667-678. doi:10.1016/S2468-1253(20)30126-6

Ghweil Ali A. “Characteristics, Outcomes and Indicators of Severity for COVID-19 among Sample of ESNA Quarantine Hospital's Patients, Egypt: A Retrospective Study.” Infection and drug resistance. 2020; 13: 2375-2383. doi:10.2147/IDR.S263489

Omran D. “Predictors of severity and development of critical illness of Egyptian COVID-19 patients: A multicenter study.” PloS one. 2021; 16(9): e0256203., doi:10.1371/journal.pone.0256203

Mubarik S. “The Association of Hypertension with the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study.” Frontiers in medicine. 2021; 8(6): 23608. doi:10.3389/fmed.2021.623608

Guido J, Guido G. Age and Multimorbidity Predict Death Among COVID-19 Patients. Results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020; 76:366–372

He Xiaobo. “Clinical Symptom Differences between Mild and Severe COVID-19 Patients in China: A Meta-Analysis.” Frontiers in public health. 2021; 8: 561264. doi:10.3389/fpubh.2020.561264

Xu Wan. “Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning.” Scientific reports. 2021; 11(1): 2933. doi:10.1038/s41598-021-82492-x

Weibiao Z, Kai Qi. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis, European Journal of Gastroenterology & Hepatology: February 2022; 34(2): 168-176 doi: 10.1097/MEG.0000000000002072

Mao L. “Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China.” JAMA neurology. 2020; 77(6): 683-690. doi:10.1001/jamaneurol.2020.1127

Merkler A. “Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza.” medRxiv: the preprint server for health sciences 2020; 05(18): 20105494. doi:10.1101/2020.05.18.20105494. Preprint.

Sarkar D. “Ocular manifestations of RT-PCR-confirmed COVID-19 cases in a large database cross-sectional study.” BMJ open ophthalmology. 2021; 6(1): e000775. doi:10.1136/bmjophth-2021-000775

Dockery DM. “The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.” The Journal of emergency medicine. 2020; 59(1): 137-140. doi:10.1016/j.jemermed.2020.04.060

Muhammad A. “Dermatological Manifestations of COVID-19 in Patients Reporting to a Tertiary Care Hospital in Rawalpindi, Pakistan.” Cureus. 2021; 13(10): e18973. doi:10.7759/cureus.18973

Méndez M. “Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital.” International journal of dermatology. 2020; 59(11): 1353-1357. doi:10.1111/ijd.15180

Fei Z, Ting Yu. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England).2020; 395(10229): 1054–1062.

Shi S. “Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China.” JAMA cardiology. 2020; 5(7): 802-810. doi:10.1001/jamacardio.2020.0950

Ferguson J. “Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.” Emerging infectious diseases. 2020; 26(8): 1679-1685. doi:10.3201/eid2608.201776

Grillet F. “Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography.” Radiology. 2020; 296(3): E186-E188. doi:10.1148/radiol.2020201544

Yildirim C. “Early predictors of acute kidney injury in COVID-19 patients.” Nephrology (Carlton, Vic.). 2021; 26(6): 513-521. doi:10.1111/nep.13856

Published

31-05-2022

How to Cite

Soliman, G. M. M., El –Dessouky, Y. M. M., & Mohamed, R. S. . (2022). Extrapulomnary-extragastrointestinal manifestations in patients with COVID-19. International Journal of Health Sciences, 6(S4), 2831–2842. https://doi.org/10.53730/ijhs.v6nS4.8190

Issue

Section

Peer Review Articles